Prestige Consumer Healthcare Financial Statements
NYSE: PBHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Prestige Consumer Healthcare revenue and earnings
In fiscal 2026, Prestige Consumer Healthcare generated $1.09 billion in revenue, down 4.3% from fiscal 2025, its first annual decline since 2024. Net income was $190.3 million (-11.3% year over year), for a net margin of 17.5% versus a median of 18.6% in the prior 5 years. Gross margin was 54.7% (down from 55.8%) and operating margin 28.4%.
Diluted earnings per share came in at $3.91, down from $4.29. Over the last 5 fiscal years, PBH's revenue has grown at a 2.9% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Prestige Consumer Healthcare income statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.09B | 1.14B | 1.13B | 1.13B | 1.09B | 943.37M | 963.01M | 975.78M | 1.04B | 882.06M |
| Revenue growth (YoY) | -4.31% | +1.10% | -0.21% | +3.76% | +15.21% | -2.04% | -1.31% | -6.28% | +18.04% | +9.40% |
| Cost of Revenue | 493.13M | 503.30M | 500.91M | 502.43M | 466.17M | 395.89M | 410.79M | 420.20M | 464.67M | 381.77M |
| Gross Profit | 595.58M | 634.46M | 624.45M | 625.29M | 620.65M | 547.47M | 552.22M | 555.58M | 576.50M | 500.29M |
| Operating Expenses | 286.17M | 297.69M | 282.02M | 647.71M | 290.73M | 250.07M | 261.07M | 488.07M | 361.03M | 294.64M |
| Operating Income | 309.41M | 336.77M | 342.43M | -22.41M | 329.92M | 297.40M | 291.15M | 67.50M | 215.47M | 205.64M |
| Interest Expense | — | 1.80M | 5.20M | 4.40M | 64.29M | 82.33M | 96.22M | 105.08M | 106.27M | 93.55M |
| Other Income (Expense) | -9.57M | -4.95M | 756.00K | -2.34M | -1.05M | 1.37M | -1.63M | -476.00K | 392.00K | -30.00K |
| Pretax Income | 257.50M | 284.19M | 276.02M | -93.92M | 262.46M | 204.11M | 191.15M | -38.05M | 107.09M | 110.85M |
| Income Tax | 67.19M | 69.58M | 66.69M | -11.61M | 57.08M | 39.43M | 48.87M | -2.25M | -232.48M | 41.45M |
| Net Income | 190.30M | 214.60M | 209.34M | -82.31M | 205.38M | 164.68M | 142.28M | -35.80M | 339.57M | 69.39M |
| Net Income growth (YoY) | -11.32% | +2.52% | — | -140.07% | +24.71% | +15.74% | — | -110.54% | +389.33% | -30.54% |
| EPS (Basic) | 3.93 | 4.32 | 4.21 | -1.65 | 4.09 | 3.28 | 2.81 | -0.69 | 6.40 | 1.31 |
| EPS (Diluted) | 3.91 | 4.29 | 4.17 | -1.65 | 4.04 | 3.25 | 2.78 | -0.69 | 6.34 | 1.30 |
| Shares Outstanding (Basic) | 48.46M | 49.70M | 49.76M | 49.89M | 50.26M | 50.21M | 50.72M | 52.07M | 53.10M | 52.98M |
| Shares Outstanding (Diluted) | 48.72M | 50.08M | 50.18M | 49.89M | 50.84M | 50.60M | 51.14M | 52.07M | 53.53M | 53.36M |
| EBITDA | 340.68M | 366.95M | 373.10M | 10.21M | 362.01M | 327.57M | 320.15M | 99.28M | 248.90M | 231.44M |
| Gross Margin | 54.71% | 55.76% | 55.49% | 55.45% | 57.11% | 58.03% | 57.34% | 56.94% | 55.37% | 56.72% |
| Operating Margin | 28.42% | 29.60% | 30.43% | -1.99% | 30.36% | 31.53% | 30.23% | 6.92% | 20.70% | 23.31% |
| Net Margin | 17.48% | 18.86% | 18.60% | -7.30% | 18.90% | 17.46% | 14.77% | -3.67% | 32.61% | 7.87% |
This table shows 10 annual periods of Prestige Consumer Healthcare's income statement, from FY 2026 back to FY 2017, across 18 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow PBH's reporting calendar. What is a income statement?